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Bone tissue engineeringA new sol–gel (SG) method is proposed to produce special bioactive glasses (BG_Ca family) characterized by a
low tendency to devitrify. These formulations, derived from 45S5 Bioglass®, are characterized by a high content
of CaO (45.6 mol%) andby a partial or complete substitution of sodiumoxidewith potassiumoxide (total amount
of alkaline oxides: 4.6 mol%), which increases the crystallization temperature up to 900 °C. In this way, it is pos-
sible to produce themby SGpreserving their amorphous nature, in spite of the calcination at 850 °C. The sintering
behavior of the obtained SG powders is thoroughly investigated and the properties of the sintered bodies are
compared to those of the melt-derived (M) counterparts. Furthermore, the SG glass powders are successfully
used to produce scaffolds by means of a modiﬁed replication technique based on the combined use of polyure-
thane sponges and polyethylene particles. Finally, in the view of a potential application for bone tissue engineer-
ing, the cytotoxicity of the produced materials is evaluated in vitro.39 059 2056243.
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At the beginning of the '70s, Hench et al. were the ﬁrst authors to
document that some glasses in the Na2O–CaO–P2O5–SiO2 system can
form a strong interfacial bond with bone tissue [1]. This property is im-
putable to the development on their surface, when they are in contact
with biological ﬂuids, of a hydroxycarbonated apatite (HCA) layer,
which is analogue to the mineral phase of bones. Later works also dem-
onstrated that speciﬁc bioactive glasses can even bond with soft tissue
through the attachment of collagen to their surface [2]. More recently,
it has been reported that bioactive glasses inﬂuence the cellular behav-
ior and the production of extra-cellular matrix through their surface
chemistry, topography and, in particular, their ionic dissolution prod-
ucts [3–5]. Historically, the most important glass in the Na2O–CaO–
P2O5–SiO2 system is the so-called 45S5 Bioglass®, which has been
used in a number of clinical applications in the orthopedic and dental
ﬁeld since the mid-1980s.
Bioactive glasses are often prepared by conventional melting
(M) methods, i.e. by heating the precursor mixture of raw materials
and then quenching the molten liquid to form a glass. In the last years,
however, many efforts have been focused on the fabrication of bioactive
glasses by means of the sol–gel (SG) technique, which was proposed in
the early '70s as a promising and particularly versatile alternative routeto synthesize glasses [6,7]. The SG method offers several advantages
with respect to the conventional melting technique. First of all, it
makes it possible to obtain extremely ﬁne (sub-micrometric) powders,
with a very controlled composition. Then it requires relatively low pro-
cessing temperatures and allows for the production of glasses with
higher homogeneity and purity than those obtained by the traditional
melting/cooling route [6,7]. Moreover SG glasses are bioactive in a
wider range of compositions than conventional melt-derived ones,
mainly thanks to their higher porosity, which results in a larger speciﬁc
surface area and, hence, in a superior dissolution rate [8–11]. In particu-
lar, if the Na2O–CaO–P2O5–SiO2 system is considered, it is reported that
M bioglasseswithmore than 60mol% SiO2 are biologically inactive [10];
on the contrary, SG glasses with 85 mol% SiO2 maintain their bioactive
behavior. At the same time, the composition of SG glasses can be varied
over wide ranges, thus providing the possibility to investigate the bio-
logical effect of different organic and inorganic dopants, such as Sr, Zn,
Ag, Mg, and Sm, in order to develop new formulations tailored for spe-
ciﬁc applications [12–15]. Finally, as stressed by Hench [4], the SG pro-
cessing helps to control the ion dissolution rates from bioglasses in
physiological solutions. Nonetheless, most of the SG bioactive glasses
reported in literature are binary or ternary systems which include
only SiO2, CaO and P2O5, but not alkaline oxides such as Na2O. This is
due to the high hydrolytic reactivity of sodium alkoxide (the ordinary
SG precursor for Na2O), which makes the production of Na2O–CaO–
P2O5–SiO2 glasses a demanding task from a technological point of
view. Since alkaline oxides play a key role in the biological performance
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cludes Na2O, is recognized as the “gold” standard for bioactive glasses,
the production and assessment of quaternary glasses by means of the
SGmethod are fundamental issues [18]. In consequence, someprotocols
aiming to incorporate Na2O into SG glasses synthesized under ambient
conditions have been attempted. In 2010 Chen et al. obtained ﬁne pow-
ders of SG 45S5 glass–ceramic employing NaNO3 as precursor for Na2O
[19]. One year later, the same authors also presented simple SG 45S5 ce-
ramic foams, produced by means of the addition of a surfactant com-
bined with mechanical stirring and subsequent sintering. However,
the microstructure of these prototypal scaffolds was not satisfactory
due to their almost closed porosity which prevents cell inﬁltration
[17]. A systematic study on the compositional, microstructural and
sintering behavior of SG 45S5 has been attempted very recently by
Cacciotti et al. [20], while Siqueira and co-workers produced bioactive
ceramic powders of the quaternary Na2O–CaO–P2O5–SiO2 system,
choosing NaNO3 as precursor for Na2O and testing triethylphosphate
and phosphoric acid as precursors for P2O5 [21]. The main drawback
of these protocols is that the full thermal decomposition of NaNO3 oc-
curs at about 680 °C [22], while the crystallization temperature of
45S5 is about 600 °C [23,24]. For this reason, the heat treatment con-
verts the gel into a ceramic powder (mainly Na2Ca2Si3O9 and Na2Ca3Si6-
O16) instead of a glass. Unfortunately, although the crystallization may
improve the mechanical properties of the fully dense bodies, it may
also limit their bioactivity, since the newly formed crystal phases are
scarcely bioactive compared to the starting glass [24–30].
In order to limit the tendency to crystallize with respect to 45S5, al-
ternative bioactive glasses belonging to the Na2O–CaO–P2O5–SiO2 fam-
ily have been recently proposed. The ﬁrst composition, named BG_Ca,
was characterized by a relatively high CaO-to-Na2O ratio (BG_Ca com-
position in mol%: 4.6 Na2O; 45.6 CaO; 2.6 P2O5; 47.2 SiO2) and it was
successfully employed for the fabrication of hydroxyapatite-based
biocomposites [31–33]. Subsequently, in order to further improve the
thermal stability of the glass, two novel glasses were developed from
the original BG_Ca formulation, with a partial (BG_Ca/Mix) or complete
(BG_Ca/K) substitution of sodium oxide with potassium oxide (BG_Ca/
Mix composition in mol%: 2.3 Na2O; 2.3 K2O; 45.6 CaO; 2.6 P2O5; 47.2
SiO2; BG_Ca/K composition in mol%: 4.6 K2O; 45.6 CaO; 2.6 P2O5; 47.2
SiO2) [34,35]. All these glasses have beenproduced so far by the conven-
tional melt-quenching technique, but their extremely high crystalliza-
tion temperature (about 880 °C for BG_Ca/Mix and 920 °C for BG_Ca/
K [34]) opens the intriguing possibility to produce them by SG and to
preserve their amorphous character. So the present contribution pro-
poses a new protocol to produce the BG_Ca, BG_Ca/Mix and BG_Ca/K
glasses by means of the SG method. According to the original work by
Chen et al., NaNO3 was used to introduce Na2O [17]; instead, KNO3
was employed as precursor for K2O in the BG_Ca/Mix and BG_Ca/K
glasses. Moreover, the sintering behavior of the obtained powders and
the thermal evolution of their crystalline phases were carefully ana-
lyzed. Themicrostructure and related properties of the SG sintered bod-
ies were investigated and compared to those of the M counterparts.
Particular attentionwas paid to their bioactivity, whichwas preliminary
assessed in vitro by means of the procedure proposed by Kokubo and
Takadama [36]. Cytotoxicity tests based on in vitro cell culture were
also performed in order to evaluate the biocompatibility of the pro-
duced materials. To conclude, the feasibility of SG glass-derived scaf-
folds was assessed.
2. Materials and methods
2.1. Sol–gel synthesis
The BG_Ca, BG_Ca/Mix and BG_Ca/K glasses [33,34] were synthe-
sized by hydrolysis and polycondensation of stoichiometric amounts
of tetraethyl orthosilicate (TEOS, Si(OC2H5)4, Sigma Aldrich),
triethylphosphate (TEP, OP(C2H5O)3, Sigma Aldrich) and calciumnitrate tetrahydrate (Ca(NO3)2·4H2O, Sigma Aldrich); in addition
to these common precursors, sodium nitrate (NaNO3, Carlo Erba
Reagenti, Italy) was added to prepare BG_Ca and BG_Ca/Mix, while
potassium nitrate (KNO3, Carlo Erba Reagenti, Italy) was added for
BG_Ca/Mix and BG_Ca/K. A ﬂowchart of the steps followed to pre-
pare the gel powders and to induce their subsequent conversion
into glass (or glass–ceramic, depending on the gel formulation) is re-
ported in Fig. 1. Starting with the hydrolysis of TEOS, each chemical
was consecutively added into a HNO3 (Carlo Erba Reagenti, Italy)
aqueous solution (0.1 M) at 30-minute intervals under continuous
magnetic stirring and only when the solution had become complete-
ly clear. The process was performed at room temperature. After
adding the last chemical, the resultant solution was maintained at
room temperature for 4 h without stirring and then stored at 35 °C
for three days. Subsequently, the gels were dried for six days at
50 °C and for three more days at 110 °C. At the end of the drying
step, the gels were ball-milled in a ceramic jar and sieved to a ﬁnal
grain size below 68 μm. For the sake of clarity, in the following dis-
cussion, the dried, milled and sieved gels will be referred to as “as-
dried gel powders”.
The as-dried gel powders were converted into glass/glass–ceramic
powders by heat-treating them in an electric furnace. The speciﬁc
heating programs were deﬁned according to the results of the differ-
ential thermal analysis (DTA) and thermo-gravimetric (TG) analysis
performed on the as-dried gel powders, as reported more in detail in
the next paragraphs. So the as-dried gel powders were calcined at
different temperatures (i.e. 700 °C, 800 °C, 850 °C, 900 °C, 1000 °C)
with 5 °C/min heating rate and 1 h dwelling time.
2.2. Preparation of glass powders by melting
The BG_Ca, BG_Ca/Mix and BG_Ca/K glasses were also produced by
means of the conventional melt-quenching technique (M), i.e. by melt-
ing the raw powders (SiO2, Ca3(PO4)2, CaCO3, Na2CO3 and/or K2CO3 by
Carlo Erba Reagenti, Italy) in a platinum crucible at 1450 °C, as reported
in [33,34]. The melt was quenched in water to obtain a frit, which was
ground in a porcelain jar and then sieved below 68 μm. For comparison
purposes, part of the M powders (named heat-treated-M) were ther-
mally treated at different temperatures (i.e. 700 °C, 800 °C, 850 °C,
900 °C, 1000 °C) with a heating rate of 5 °C/min and 1 h dwelling
time, according to the same schedules used for the calcination of the
SG counterparts.
2.3. Powder characterization
The thermal behavior of the as-dried gel powders was investigated
by means of simultaneous thermogravimetry, TG, and differential ther-
mal analysis, DTA (NETZSCH DSC-TG 409, NETZSCH-Gerätebau GmbH,
Selb, Germany). The powders were heated from room temperature to
1200 °C with a heating rate of 10 °C/min.
In order to analyze the possible heat-induced crystallization phe-
nomena X-ray diffraction (XRD) analyses (X'Pert PRO, PANalytical,
Almelo, The Netherlands) were performed on the as-dried gel pow-
ders and on the M powders, before and after heat-treatment at dif-
ferent temperatures (i.e. 700 °C, 800 °C, 850 °C, 900 °C, 1000 °C, as
previously mentioned). Cu kα radiation in the 10°–70° 2θ angular
range, with steps of 0.017° and a scanning rate of 0.02° s−1, was
employed. The powders were also observed in an Environmental
Scanning Electron Microscope (ESEM Quanta 2000, FEI Co., Eindho-
ven, The Netherland). The SEM was operated in low-vacuum mode
with a pressure of 0.53 Torr. Qualitative compositional analyses
were performed by means of X-ray energy dispersion spectroscopy
(EDS) (Inca, Oxford Instruments, UK). In the following, both the
XRD and the ESEM facility will be employed in the abovementioned
conﬁguration without any further speciﬁcation.
Fig. 1. Flowchart of the production process.
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As described in the following “Results and discussion” section,
taking into account the results of DTA, EDS and X-ray diffraction,
only SG powders calcined at 850 °C for 1 h were chosen for further
investigations. Therefore, the label “SG” will henceforth indicate
these powders without further speciﬁcations. The sintering behavior
of the SG powders was evaluated by means of an optical dilatometer
(Misura 3.32; Expert System Solutions, Modena, Italy). The test was
performed on 5 × 5 × 15 mm3 samples of pressed powder treated
from room temperature to 1000 °C at 10 °C/min. According to the di-
latometric tests, the best sintering temperature, which corresponds
to the maximum contraction rate, is about Tsint = 800 °C for SG
BG_Ca, SG BG_Ca/Mix and SG BG_Ca/K. Therefore, the powders
were mixed for 6 h, wettedwith 10wt.% of acetone and subsequently
pressed at 60 MPa for 15 s in order to obtain 15 mm-diameter disks
(green bodies). The green bodies were then sintered at Tsint for 3 h
(heating rates of 5 °C/min from room temperature to 500 °C and of
10 °C/min from 500 °C to 800 °C) in order to obtain SG BG_Ca, SG
BG_Ca/Mix and SG BG_Ca/K dense bodies. According to preliminary
tests (data not shown), the duration of the sintering isotherm (3 h
at 800 °C) was chosen to achieve a complete densiﬁcation. For com-
parison purposes, M BG_Ca, M BG_Ca/Mix and M BG_Ca/K powders
were processed in the same way to prepare green bodies and then
they were sintered at the same temperature Tsint = 800 °C. Indeed
it is worth noting that, according to previous investigations, such
temperature is also appropriate to obtain dense sintered body
starting from melt-derived powders of the BG_Ca family [33,34].
The shrinkage (in percent), Δ%, due to the densiﬁcation process was
calculated according to the following equation:
Δ% ¼
d0−dexp
d0
 100 ð1Þ
where d0 is the nominal diameter of themold of the press (15mm) and
dexp is the diameter of the sample after heat treatment (experimentallymeasured). For each SG and M powder ﬁve samples were considered
and mean values were calculated.
As already done for the loose powders, an XRD was performed on
the SG and M sintered bodies aiming to study the heat-induced de-
velopment of crystalline phases possibly occurred as a result of the
sintering process. The microstructure of the surface of the samples
and of their polished cross-section was investigated with an ESEM.
2.5. Scaffold preparation and characterization
In this feasibility study only SG BG_Ca/K powders were considered
for the production of scaffolds. In particular, the SG BG_Ca/K powders
were used to fabricate a new kind of scaffolds, called “shell scaffolds”.
The name derives from the peculiar morphology of such scaffolds,
which combines a foam-like internal structure with a very robust
(but still porous) external surface, i.e. the “shell” [37,38]. The proce-
dure to manufacture bioceramic shell scaffolds is just summarized
here, since it has been recently described in detail elsewhere [37,
38]. First of all, ceramic slurries were prepared with 32 wt.% SG
BG_Ca/K powders, 6 wt.% polyvinyl alcohol (PVA), 5 wt.% polyethyl-
ene powder and 57wt.% distilled water. The addition of polyethylene
particles helps to control the ﬁnal porosity, especially at the outer
surface, where the burning-out of the particles during the heat treat-
ment is expected to result in large pores, which are able to favor an ad-
equate cell inﬁltration. Commercial polyurethane sponges [39], which
act as organic templates for scaffolds, were then immersed in the slurry,
extracted without squeezing and immediately dried in a multidirec-
tional air ﬂux in order to obtain green bodies. In this sense, as pointed
out in Refs. [37,38], such procedure completely differs from the tradi-
tional foam replication method, where
• Polyethylene powders are not involved;
• Sponges after soaking are squeezed and then dried very slowly.
The green bodies were heat-treated at Tsint = 800 °C for 3 h in a
ventilated kiln in order to remove the organic template and the poly-
ethylene particles, and to sinter the ceramic phase.
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pore content of the scaffolds was calculated by means of the following
equation
P% ¼ 1−
W f
Wt
 
 100 ð2Þ
whereWf stands for the measured weight of the sample andWt stands
for the theoretical one, which can be calculated bymultiplying the scaf-
fold volume by the glass theoretical density. The scaffold total porosity
was also estimated by means of image analysis, as an alternative
route. To this aim, an open-source software (ImageJ, see http://
rsbweb.nih.gov/ij/) was employed and ﬁve different samples were con-
sidered. According to the protocol described in Refs. [40,41], capillarity
tests were carried on with the aim to qualitatively evaluate the perme-
ability of the produced scaffolds and the presence of an interconnected
pores network. For this purpose, the samples were put in contact with a
solution with a viscosity similar to physiological ﬂuids [40,41]. Blue ink
drops were dispersed into the solution to highlight the ﬂuid adsorption
through the scaffold's porosity due to capillarity forces. The samples
were ﬁnally cut in two pieces in order to verify the solution up-take in
their inner part.
Even if the present contribution explores only the feasibility of
scaffolds derived from sol–gel calcined powders and the detailed
characterization is deferred to a speciﬁc future contribution, a pre-
liminary mechanical test was performed on the scaffolds produced
(at 800 °C) with the SG BG_Ca/K powders. Compression tests were
carried out on 1 cm × 1 cm × 1 cm cubic samples using a Zwick
Roell Z600; the instrument was equipped with an automatic high-
resolution digital measurement system by the same Zwick Roell.
The crosshead speed was ﬁxed at 0.01 mm/min and the stress-
deformation curve was monitored until densiﬁcation of the porous
samples started to occur. The scaffold yield strength was deﬁned as
the ratio between the maximum applied load and the cross sectional
area of the sample. Five samples were considered to have reliable
data.2.6. Evaluation of in vitro bioactivity in SBF
The bioreactivity of the obtained samples (SG BG_Ca, SG BG_Ca/Mix
and SG BG_Ca/K fully dense bodies, ﬁred at 800 °C for 3 h, and SG
BG_Ca/K shell scaffolds, also treated at 800 °C for 3 h) was evaluated
in vitro in a Simulated Body Fluid (SBF) solution, as outlined by Kokubo
et al. [36,42]. The samples were kept in closed ﬂasks, each containing
25 ml of SBF. The ﬂasks were maintained at 37 °C and the solution
was refreshed three times a week (after 2, 4, 7, 9, 11 days) to reproduce
dynamic conditions. The pHvariation induced by the sampleswasmon-
itored. After 3, 7 and 14 days in SBF, the samples were extracted, rinsed
in distilled water and left to dry at ambient conditions before further
characterization.
The changes occurred on the surface and the formation of an apatite
layer was monitored by X-ray diffraction and by direct observation in a
scanning electron microscope. Moreover, cross-sectional images were
acquired on cut and polished samples, previously mounted in resin, in
order to evaluate the thickness of the precipitates as a function of time
in SBF.
Micro-Raman spectroscopy was also performed on the samples in
order to investigate the chemical nature of the precipitated apatite. A
Jobin-Yvon RamanMicroscope spectrometer (Horiba Jobin-Yvon, Ville-
neuve d'Ascq, France) was employed (632.8 nm-wavelength He–Ne
diode laser emitting; output power of 20 mW at the sample). The
laser beam was focused on the surface of the samples by means of
50× and 100× objectives. A spectrum collection setup of 15 acquisi-
tions, each of them taking 40 s, was used.2.7. Cytotoxicity tests
The cytotoxicity of the SG sintered samples was evaluated in vitro
with BALB/3T3 (mouse embryonic ﬁbroblast cell line) cells, according
to International Standard prescriptions [43,44]. The survival/viability
of the cells was assessed by means of Neutral Red (NR) uptake and
XTT assays.2.7.1. Culture of BALB/3T3 cells and preparation of materials' extracts
BALB/3T3 cells were cultured in Dulbecco's modiﬁed Eagle's me-
dium (DMEM) (Invitrogen, Karlsruhe, Germany), supplemented
with 10% fetal bovine serum (Invitrogen), L-Glutamine 2 mM and so-
dium pyruvate 1 mM (Invitrogen) and 100 μg/ml pen-streptomycin
(Invitrogen) on 6 well plates for direct contact with the samples
dishes and the Neutral Red assay procedure was carried on (see
next paragraph). The cells were maintained in a 5% CO2 humidiﬁed
incubator at 37 °C and subcultured approximately for 72 h.
The extracts of the BG_Ca, BG_Ca/Mix and BG_Ca/K sintered
glasses were obtained by treating them in centrifuge tubes,
6 cm2/ml area each containing DMEM. A vial with 6 ml of DMEM
only was employed as negative control (CTRL−), while DMEM
with 0.45% of phenol solution was used as positive reference
(CTRL +). Vials were incubated at 37 °C for 5 days and pH was pe-
riodically measured in order to maintain physiological conditions.
Every extract was then ﬁltered by means of a 0.22 μm ﬁlter before
cytotoxicity tests [43,44].2.7.2. NR and XTT tests
The Neutral Red uptake (Neutral Red solution N6264 Sigma,
Germany) test is a sensitive andwidely used assay to estimate the num-
ber of viable cells in a culture. It is based on the ability of viable cells to
accumulate intracellularly the supravital dye neutral redwithin their ly-
sosomes [45]. Cytotoxicity is expressed as a reduction of the NR uptake
after one day (~1 doubling period) of chemical exposure to the test
material.
BALB/3T3 cells were seeded and cultured at 37 °C± 1 °C, 5.0%± 1%
CO2/air and 90% ± 5% humidity for 24 h. The culture mediumwas then
removed and 250 μL of NR solution were added to all wells. After incu-
bation, the NR solution was removed and cells were rinsed with 250 μL
D-PBS. Subsequently 100 μL NR Desorb (ETOH/acetic acid) solution was
added to all wells for 20min in order to extract NR from the cells and to
form a homogeneous solution. The test was repeated in triplicate for
each sample. The amount of dye accumulated into the cells was evaluat-
ed by means of spectrophotometry at 540 nm (Multiscan RC by
Thermolab system, Finland). As already mentioned, DMEM without
serum and phenol 0.45% were used as CTRL− and CTRL+ references,
respectively. The cells' morphology after 24 h direct contact with the
samples was observed by means of an optical microscope (Nikon TMF,
Japan).
The cell viability after exposure to the materials' extracts was fur-
ther evaluated by means of XTT test, a colorimetric assay which is
widely exploited in order to investigate both the mechanisms of
cell damage and activation [46,47]. This protocol is based on the
bioreduction of the (2,3-bis(2-methoxy-4-nitro-5-sulfophenyl)-5-
[(phenylamino) carbonyl]-2H-tetrazolium hydroxide) salt to form
an orange formazan dye in metabolic active cells. BALB/3T3 cells
were seeded in 96 well culture plates and subsequently incubated
with samples' extracts for 24 h–48 h–72 h. Then XTT (Cell Prolifera-
tion Kit II (XTT) Roche Diagnostics, USA) was added (ﬁnal concentra-
tion 0.3 mg/ml). After 4 h incubation, the amount of the synthesized
orange formazan dye generated from XTT, which directly correlates
to the number of living cells, was measured by means of spectropho-
tometry at 490 nm. DMEM without serum and phenol 0.45% were
used as CTRL− and CTRL+ references, respectively.
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One-way variance analysis (ANOVA) was employed to statistically
treat the results, which are expressed as the mean ± standard devia-
tion. t-Test analysis by a two population comparison was used to estab-
lish differences among groups. Statistical signiﬁcance was considered at
a probability p b 0.05.
3. Results and discussion
3.1. Powder characterization and calcination effects
Despite the different compositions of the glasses under investiga-
tion, the gelation time, which is the time required for the solution to
become rigid, was similar for all the obtained gels. In particular
BG_Ca, BG_Ca/Mix and BG_Ca/K gels were homogeneous, colorless
and transparent. After milling and sieving, simultaneous TG and
DTA were performed on as-dried gel powders to determine the
best treatment to convert them into glass powders. The as-dried
gel powders are expected to present signiﬁcant weight losses be-
cause of the thermal decomposition of the precursors. The results
of these tests are reported in Fig. 2. All the curves present a similar
trend, which is characterized by:
• A ﬁrst endothermic peak at about 140 °C in the DTA curves, which can
be ascribed to the desorption of physically adsorbed water [48,49];Fig. 2. TG and DTA curves of the as-dried gel powders.the TG curve shows a weight loss of about 20% (BG_Ca and BG_Ca/K)
and 10% (BG_Ca/Mix) up to 200 °C associated to this peak.
• An exothermic peak at about 250 °C, which is more evident in the DTA
curve of the BG_Ca/Mix. This peak can be ascribed to the volatilization
of water, which is an exothermic chemical desorption process [21].
• Two endothermic peaks: the ﬁrst one in the 410–420 °C range and the
second one, which is particularly pronounced, in the 580–600 °C
range. The TG curve shows the most critical mass loss between
500 °C and 650 °C. The transformations occurring in this interval can
be attributed to the decomposition of the organic precursors, to the re-
moval of nitrate groups and, at the same time, to the condensation of
the silanol groups [14,20,48,50].
• TheDTA curve of the BG_Ca gel (Fig. 2(a)) shows an endothermic peak
at about 800 °C and, subsequently, an exothermic peak at about
830 °C. The former is imputable to the glass transition and the latter
to the crystallization of the glassy matrix [51,52]. The crystallization
peak shifts to higher temperatures and gets particularly broad for the
BG_Ca/Mix gel, while it can be observed at the highest temperature,
i.e. ~930 °C, for the BG_Ca/K gel, which conﬁrms the very low tendency
to crystallize of this formulation. It is interesting to note that, according
to the DTA, the crystallization temperature of the BG_Ca/K as-dried gel
powders (i.e. ~920 °C) is the same as that previously detected for M
powders of the same composition [34].
• Starting from 820 °C all the TG curves reveal a substantial stability of
the powders, except for the BG_Ca/K which experiences a slight mass
loss up to about 850 °C.
XRD patterns of the gel powders calcined at different temperatures
for 1 h are reported in Fig. 3. In agreement with the thermal analysis,
BG_Ca/K remained substantially amorphous up to 900 °C, while BG_Ca
remained amorphous up to 800 °C and BG_Ca/Mix up to 700 °C. To
the authors' best knowledge, no other SG bioactive glasses in theFig. 3. XRD patterns of the gel powders treated at different temperatures for 1 h.
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the BG_Ca/K can be surely included among the SG bioactive systems
with the highest crystallization temperature. Therefore, like the M
counterparts, also the SG glasses beneﬁt from the high CaO content
and from the partial (or complete for BG_Ca/K) substitution of sodi-
um oxide with potassium oxide in their formulation [33,34]. During
the calcination, the crystallization of the SG BG_Ca samples results
in a sodium calcium silicate, Na2CaSiO4 (ICDD 00-024-1069), and a
calcium silicate, CaSiO3 (ICDD 00-002-0506) (Fig. 3a). The SG
BG_Ca/Mix samples crystallize with the development of the same so-
dium calcium silicate, Na2CaSiO4 (ICDD 00-024-1069), and ofFig. 4. SEM micrographs of the SG powders and heat-wollastonite (ICDD 01-076-0925) (Fig. 3b). The crystallization of
the BG_Ca/K samples starts at about 900 °C, but the peaks are still
very weak and their attribution to wollastonite (ICDD 01-076-
0925) becomes unambiguous only at 950 °C (Fig. 3c). The M coun-
terparts substantially show the formation of the same crystalline
phases, i.e. wollastonite and sodium–calcium silicates [33,34],
whose in vitro bioactivity has been widely documented in literature
[53–56].
Fig. 4 compares the SEMmicrographs of the SG powders to those of
the heat-treated-M counterparts after thermal treatment at 850 °C for
1 h. The spectra of the EDS analyses are also reported and it should betreated-M counterparts calcined at 850 °C for 1 h.
Fig. 6. Thermo-dilatometric curve of the calcined SG BC_Ca/K powders.
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imputable to residues of precursors in the SG powders.
On the basis of TG-DTA, XRD and EDS analyses, the SG powders
calcined at 850 °C for 1 h were chosen for further investigation and
therefore the following discussion will be dedicated to such calcined
powders only. For this reason, in the following discussion, the label
“SG” will be used to indicate the sol–gel samples treated at 850 °C
for 1 h without any further speciﬁcations. This temperature, 850 °C,
was selected as a compromise between the need to decompose the
precursors completely (according to the DTA, the BG_Ca/K presents
a slight mass loss up to about 850 °C) and the possibility to minimize
the devitriﬁcation (according to the XRD, the BG_Ca/Mix starts its
crystallization at 700 °C, but 850 °C is comparable to the crystalliza-
tion temperature of the BG_Ca glass and it is deﬁnitely lower than
that of BG_Ca/K, which remains substantially amorphous up to
900 °C). For comparison, the XRD spectra obtained on heat-
treated-M powders after heat treatment at 850 °C for 1 h are report-
ed in Fig. 5. In agreement with previous results regarding the same
compositions [33,34], heat-treated-M BG_Ca undergoes crystalliza-
tion with the formation of Na2CaSiO4, while heat-treated-M BG_Ca/
Mix and heat-treated-M BG_Ca/K remain substantially amorphous.
So it is interesting to note that, if melt-derived glasses are consid-
ered, the BG_Ca composition has the lowest crystallization tempera-
ture (it is partially crystallized after 1 h at 850 °C, whereas both the
BG_Ca/K and BG_Ca/Mix compositions are still amorphous after the
same heat treatment); if sol–gel glasses are considered instead, the
SG BG_Ca/Mix glass is the ﬁrst one to devitrify, since it starts to crys-
tallize after 1 h at 800 °C (see Fig. 3(b)).
3.2. Sintering behavior and microstructure characterization of fully dense
bodies
The sintering temperature of the SG calcined powders was deter-
mined by an optical thermo-dilatometric analysis. The curve of SG
BG_Ca/K powder is shown in Fig. 6. The curves obtained for SG BG_Ca
and SG BG_Ca/Mix are omitted for the sake of brevity, since they are
very similar to the BG_Ca/K one. A signiﬁcant contraction can be ob-
served in the 760 °C–830 °C range and the best sintering temperature,
which corresponds to the maximum shrinkage rate, can be ﬁxed at
Tsint=800 °C. If the temperature increases, the sample starts to expand.
Unfortunately, the test suddenly interrupts at about 850 °C due to an
experimental limit, since the sample expands so fast that the instrument
is not able to track it. Similar expansion phenomena have been reported
in the literature also for sol–gel 45S5 Bioglass® [20]. According to the re-
sults of the thermo-dilatometric analysis, therefore, SG green bodies
were treated at Tsint = 800 °C for 3 h. Indeed, it cannot be excluded
that a second sintering step might occur at a higher temperature, as re-
ported in the literature for M glasses of the same BG_Ca family [33,34]
and for SG 45S5 Bioglass® [20]. However, a treatment at 800 °C is ex-
pected to promote a strong densiﬁcation (see dilatometric curve,
Fig. 6) and, at the same time, to limit the crystallization.Fig. 5. XRD patterns of the heat-treated-M powders after thermal treating at 850 °C for 1 h.The cross-sections of the SG samples sintered at 800 °C for 3 h are
shown in Fig. 7. The SEM images conﬁrm that all the samples are
compact and well consolidated. The corresponding values of density
and volume shrinkage, expressed as mean value ± standard devia-
tion, are reported in Table 1. For comparison, M green bodies were
produced and heat treated with the same thermal cycle. The density
and the volume shrinkage of the M samples sintered at Tsint are also
reported in Table 1. It is possible to note that the volume shrinkage of
the M samples is remarkably stronger with respect to the SG coun-
terparts, in particular for the BG_Ca/Mix glass. It cannot be excluded
that a slight development of gaseous by-products might occur during
sintering, as lately proposed for SG 45S5 Bioglass® [20]. It should be
stressed that, as a rule, relevant volume shrinkages may be detri-
mental to produce highly porous scaffolds for bone regeneration
and repair, since strong dimensional changes during the sintering
process may result in the formation of a poorly interconnected po-
rosity with clogged pores. In fact, the M glasses belonging to the
BG_Ca family, which experience a remarkable volume change, are
not suitable for the production of pure glass scaffolds. On the con-
trary, the SG counterparts seem to be ideal candidates to manufac-
ture highly porous devices, as reported in the next paragraphs.
The XRD spectra acquired on the SG samples sintered at 800 °C
for 3 h are presented in Fig. 8. The XRD test was repeated on the
sintered samples, because the very long treatment (3 h) at 800 °C
could favor the development of (new) crystalline phases. However,
it is interesting to note that it was possible to preserve the amor-
phous nature of SG BG_Ca/K glass, which was still amorphous at
the end of the sintering process. This result further conﬁrms the ex-
traordinary low tendency to crystallize of the SG BG_Ca/K glass. In-
stead the BG_Ca and BG_Ca/Mix sintered samples were partially
crystallized, but this is not surprising, since the powders were al-
ready partially crystallized after the calcination step (Fig. 3).
3.3. SG BG_Ca/K shell scaffolds
In previous contributions [37,38], shell scaffolds were produced by
means of a new protocol inspired by the traditional foam replication
technique [29]. Themain objectivewas to obtain highly porous samples
which could be easy to handle thanks to their external surface, acting as
a resistant but at the same time permeable shell, i.e. a sort of exoskele-
ton which supports the inner sponge-like network [37]. However, in
order to produce such samples, conventional melt-derived glass pow-
ders were used and relatively high temperature treatments (~1050 °C
for 3 h) were necessary to consolidate the scaffolds, which therefore re-
sulted to be crystallized [37,38].
In the present contribution, since the thermal behavior of the SG
BG_Ca/K powders was extremely promising, an attempt was made to
Fig. 7. Cross-sections of the SG samples sintered at 800 °C for 3 h.
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samples due to the unique properties of sol–gel derived glass powders.
The SG BG_Ca/K shell scaffolds looked extremely porous, but still
easy to handle, due to the strong outer “shell”. The permeability of
the scaffolds' surface (i.e. the “shell”) was qualitatively conﬁrmed
by means of capillarity tests performed according to the protocol re-
ported in Refs. [40,41]. In Fig. 9 it is possible to observe a sample dur-
ing (Fig. 9(a, b)) and immediately after (Fig. 9(c)) the test. In about 3
s the whole scaffold became blue as a result of the ﬂuid inﬁltration
through its pore network. After the ﬂuid adsorption, each sample
was cut in two pieces to observe its cross-section. The scaffolds
were uniformly impregnated and, in particular, the presence of the
blue solution in their interior further conﬁrms the permeability of
the samples' surface and their open and fully interconnected porous
structure.
The total porosity of the samples, as calculated from density mea-
surement and further conﬁrmed by image analysis, was about
80 vol.%. SEM micrographs of the internal structure of the SG
BG_Ca/K shell scaffolds are reported in Fig. 10. It should be noted
that the complex network of struts and macropores reproduces the
shape of the spongy template [39]. The pores of the scaffolds are
mostly open and interconnected, a result which had never been
reached in the past with M glass powders of the BG_Ca family. As
shown in Fig. 10, the SG BG_Ca/K shell scaffolds are characterized
by a macroporosity whose size is between 200 μm and 500 μm, a
value which satisﬁes the requirements to allow cell inﬁltration and
new vascularization [57]. Moreover the scaffolds present a wide-
spread microporosity, which is able to promote the diffusion of
ﬂuids, and by a rough surface of the struts, which is expected to
help cell adhesion after implantation [58]. In fact, as shown in the
high-magniﬁcation image, Fig. 10(d), the morphology of the original
particles is still perceivable on the surface of the splats. Unfortunately, a
direct measurement of the roughness of the struts is not feasible, due to
the complex shape of the scaffolds and the very ﬁne dimension of the
original particles. Finally, it should be stressed that the obtainedTable 1
Density (mean value ± standard deviation) and volume shrinkage (mean value ± -
standard deviation) of the SG samples and of theM counterparts sintered at Tsint = 800 °-
C for 3 h.
Sample code Manufacturing process Density (g/cm3) Volume shrinkage (%)
BG_Ca Sol–gel 1.43 ± 0.15 13.88 ± 0.65
Melting 2.47 ± 0.12 17.08 ± 1.13
BG_Ca/Mix Sol–gel 1.33 ± 0.14 2.17 ± 0.08
Melting 2.53 ± 0.15 17.62 ± 0.58
BG_Ca/K Sol–gel 1.29 ± 0.12 9.42 ± 0.17
Melting 2.53 ± 0.28 16.93 ± 0.99samples are almost amorphous (data not shown) and therefore they
are expected to be highly bioactive.
In spite of their rich porosity, the scaffolds proved to have good
mechanical properties. In fact, during the compression tests, the
stress increases moderately in a ﬁrst stage, and very quickly in a sec-
ond stage, with a maximum yield strength of about 0.6–0.7 MPa;
after that, the stress drops, due to the progressive break down of
the structure. The same behavior has been observed in the past for
shell scaffolds produced with melt-derived glass powders [37]. The
mechanical behavior is therefore mainly governed by the structure
of the scaffolds, especially by the presence of the external shell,
whereas the technique to produce the powders, sol–gel instead of
melting, plays a marginal role. It is worth noting that the achieved
yield strength is comparable to or even higher than the compressive
strength commonly reported in the literature for glass-based scaf-
folds, produced by standard replication method, from melt-derived
powders and with analogous total porosity [29,37,59,60]. On the
contrary, a comparison with the mechanical strength of spongy
bone is not straightforward, since bone has anisotropic mechanical
properties characterized by heterogeneity with respect to anatomic
site, age, health and disease-related variations in trabecular architec-
ture, loading mode and direction. However, the yield strength of the
sol–gel derived scaffolds is compatible with the compression resis-
tance of spongy bone, which is in the 0.3–8 MPa range [61], although
it lies closer to the lower bound. Other authors in the literature re-
port an even wider range for the mechanical strength of spongy
bone, i.e. 0.1–30 MPa [62].
3.4. Assessment of the in vitro bioactivity
The apatite-forming ability of the produced SG-samples (dense
sintered bodies and scaffolds) was tested in vitro through the immer-
sion in a Simulated Body Fluid (SBF) solution for a given period ofFig. 8. XRD patterns of the SG samples sintered at 800 °C for 3 h.
Fig. 9. Capillarity test performed on a shell scaffold.
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few years several authors have questioned the predictive ability of these
assays, which cannot mimic the real physiological conditions and mayFig. 10. SEMmicrographs showing the internal structure of the SGlead to misunderstand the behavior of a given material once embedded
in a biological context [63–65]. Moreover, it should be stressed that a fa-
vorable environment in terms of ionic concentration is just one of the
many conditions necessary for bone regeneration, which is a complex,
well-orchestrated physiological process. On the other hand, even if the
apatite-forming ability is not immediately equivalent to the bone-
bonding ability, SBF trials are relatively easy and cheap and therefore
they are widely used by the scientiﬁc community. They should be con-
sidered as an introductory inquiry into the bio-reactivity of a given
non-toxic material.
Fig. 11 shows the surface of sintered (not porous) SG glass samples
(SG BG_Ca, SG BG_Ca/Mix and SG BG_Ca/K fully dense bodies, ﬁred at
800 °C for 3 h) soaked in SBF for increasing times. After 3 days, all the
samples have already started their interaction with the SBF solution
and their surface is covered by spherical aggregates with the typical ap-
atite morphology. The amount of the deposited apatite increased with
increasing soaking time, as also conﬁrmed by the cross sectional images
(data not shown for the sake of brevity). In particular, after 14 days in
SBF all samples are covered by an apatite ﬁlm which has a thickness of
some micrometers (about 2–3 μm). The results show that the SG
BG_Ca/K sample possessed the strongest apatite-forming ability. This
is probably due to the presence of potassium, which is higher in the
BG_Ca/K formulation than in the other two. As a matter of fact, as re-
ported byVitale-Brovarone et al. [66] in a contribution concerning a bio-
active glass belonging to the K2O–CaO–SiO2 system, the high bioactivity
observed for their glass could be partly ascribed to the presence of K+ in
the glass formulation. According to the Hench's model [2], in fact, the
ﬁrst chemical step of the bioactivity mechanism, which leads to the ap-
atite precipitation on the glass surface, involves an exchange of alkali (or
alkaline-earth) cations from the glass with H+ or H3O+ ions from the
physiological solution. However, Na+ has a relatively small radius
(0.95 Å) if compared with K+ (1.33 Å), therefore the K+/H+ exchangeBG_Ca/K shell scaffold (sample ﬁred at T = 800 °C for 3 h).
Fig. 11. Surface of the sintered (not porous) SG glass samples soaked in SBF for increasing times.
582 D. Bellucci et al. / Materials Science and Engineering C 43 (2014) 573–586phenomena have a more “disruptive” effect on the glass matrix than
Na+/H+ ones, so the release of K+ ions is more effective to increase
the glass speciﬁc surface area available for further reactions.
The identiﬁcation of the observed globular precipitates as apatite
was conﬁrmed by EDS analysis, XRD and micro-Raman investigation.
Already after 3 days in SBF, apart from local ﬂuctuations, the EDS results
revealed the presence of P and Ca, with a Ca-to-P ratio of about 1.8,
which is comparable to the typical value of stoichiometric apatite, i.e.Fig. 12. Surface of sintered SG BG_Ca/K samples after soaking in SBF for 31.67 [67]. As an example, the EDS spectra acquired on SG BG_Ca/K sam-
ples are reported in Fig. 12. The presence of a weak Si signal in the spec-
trum (Fig. 12(b)) is imputable to the silica gel underneath the apatite
precipitates [2], while the presence of Cl is ascribable to chloride com-
pounds precipitated from the solution, as often documented in litera-
ture [68,69]. The formation of an apatite layer during the immersion
in SBF was also evidenced by the XRD analyses. The diffraction patterns
of the SG BG_Ca/K samples before and after soaking in SBF for differentdays (a) and EDS spectra (b, c) acquired on the areas reported in (a).
Fig. 13. XRD spectra of the sintered SG BG_Ca/K samples soaked in SBF for increasing
times.
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terns obtained on the SG BG_Ca and SG BG_Ca/Mix samples are similar
to the SG BG_Ca/K ones, they were not reported. Before the immersion
in SBF, as discussed in previous paragraphs, the XRD spectrum conﬁrms
the amorphous nature of the sample, since it is characterized by a broad
halo between 30° and 35° (2θ); the broad peak at about 46° (2θ) is due
to the sample holder (see Fig. 8). With increasing times in SBF, a new
halo became visible at lower diffraction angles (20°–35° 2θ range);
this “bump”, which can be connected to the silica gel layer [70] already
detected by the X-EDS analysis, is particularly evident after 7 days in
SBF. The signal at 2θ ~ 32°, which became sharper and more intense
for longer soaking times, corresponds to the (2 1 1) reﬂection of apatite.
Its broad shape, which is particularly evident for short soaking times, is
due to the microcrystalline nature of the apatite precipitates [71]. The
peak at 2θ ~ 26° also becomes very sharp and it is imputable to the (0
0 2) apatite diffraction peak, while the secondary peaks at 2θ ~ 39°
and ~46° correspond to the (3 1 0) and (2 1 3) apatite diffraction
peaks, respectively [72,73]. The obtained spectra contained peaks corre-
sponding to those of a reference apatite (ICDD 01-070-0794).
The chemistry of the precipitated apatitewas further investigated by
means of micro-Raman spectroscopy. Fig. 14 reports some illustrative
spectra acquired on the globular crystals which cover the SG glass sam-
ples after 7 days in SBF. All spectra display the characteristic peaks of ap-
atite: a peak at ~950 cm−1 and two peaks at about 430 cm−1 and
590 cm−1, which are imputable to the stretching of the (PO4)3− groups
[74,75]. In addition, a peak at ~1070 cm−1, which can be referred to the
stretching of a carbonate group, can be observed. Therefore, it is possible
to conclude that the formed apatite is carbonated [76].
The bioactivity of SG BG_Ca/K shell scaffolds (samples treated at
Tsint = 800 °C for 3 h) was investigated in the same way. The scaf-
folds' internal structure after immersion in SBF for 7 days is shown
in Fig. 15, which also includes an EDS spectrum acquired on the pre-
cipitates which cover the surface of the struts. It is evident that the
apatite agglomerates uniformly covered the internal pore walls and
the trabeculae between them. The EDS analysis revealed the pres-
ence of P and Ca in a proportion of about 1.75 (with ﬂuctuationsFig. 14. Raman spectra acquired on the globular precipitates which cover the sintered SG
glass samples after soaking in SBF for 7 days.caused by the local nature of the technique), which supports the
identiﬁcation of the precipitates as hydroxyapatite.
All the samples showed a good trend of pH neutralization during
in vitro tests. In fact, the pH of the SBF (which was refreshed three
times a week) did not exceed 8.3 and, after 14 days, almost stabilized
to physiological values (7.4–7.5).
3.5. Cytotoxicity tests
Testing the effects of new compounds and their degradation
products on the viability of cells grown in culture is a commonly
used tool to go beyond the ﬁndings from SBF assays. The main objec-
tive is to predict potential toxic effects in whole animals of materials
intended for biomedical applications. To this aim, the cytotoxicity of
the SG sintered samples was tested using BALB/3T3 mouse ﬁbroblast
cells, a very common immortalized cell line which conformswith the
International Standards Organization (ISO) requirements for investi-
gating the cytotoxicity of biomaterials [43,44]. The morphology of
the cells after 24 h direct contact with the samples was observed
bymeans of an optical microscope, as shown in Fig. 16. No signiﬁcant
morphological changes such as cell shrinkage, rounding, lysis etc. can be
observed with respect to the CTRL−. In particular, even if the composi-
tion of the samples differs, no relevant effects can be noted on the cells'
behavior. The results of the viability test performed with NR uptake
conﬁrm these considerations (see Fig. 17(a)). NR assays, which provide
a quantitative evaluation of the number of viable, damaged and dead
cells in a culture, rely on the ability of viable cells to absorb and concen-
trate the supravital dye neutral red in lysosomes [45]. The chemical
exposure to toxic xenobiotics is expected to alter this process, thus
resulting in a decreased NR uptake and binding. Cell cultures are usu-
ally examined after one cell cycle, i.e. 24 h. The results shown in
Fig. 17(a) do not report signiﬁcant reduction in the lysosomal activ-
ity of BALB/3T3 cells in contact with SG BG_Ca/K, BG_Ca/Mix and
BG_Ca. In particular, NR uptake is similar to CTRL− for all samples.
Cell viability was further evaluated by means of XTT reduction
assay, which measures metabolically active viable cells through
their ability to convert tetrazolium salts, such as XTT, MTT, MTS,
and WST, into intensely colored formazan dyes, which can be easily
measured by spectrophotometry [47,77–79]. The colored product is
proportional to the number of viable cells. XTT has become increas-
ingly popular among metabolic dyes mainly because it is reduced
by cells into a water-soluble formazan dye, thus eliminating the sol-
ubilization step required for the MTT assay, which has been the main
hurdle with viability methods for many years. The XTT results re-
ported in Fig. 17(b) show that SG sintered glasses do not affect neg-
atively the vitality of the cells. Based on this preliminary biological
evaluation, it is possible to hope for an in vivo biocompatibility of
the synthesized glasses.
4. Conclusions
In the present contribution a new protocol to produce quaternary
bioactive glasses bymeans of the sol–gel (SG)methodwas presented
and discussed. Due to the special composition of the glasses, which
are characterized by a high content of CaO (45.6 mol%) and a low
amount of alkaline oxides, Na2O and/or K2O (tot. 4.6 mol%), the tem-
perature required to decompose the chemical precursors is lower or
comparable to the crystallization temperature (in the 700–900 °C
range, depending on the speciﬁc glass composition) so, for the ﬁrst
time, it was possible to produce four-oxide bioactive glasses by the
sol–gel method and to sinter them (Tsint = 800 °C) preserving their
amorphous character, with a technological protocol which is cheaper
than those usually reported in the literature. In particular, the com-
position with the highest potassium content (BG_Ca/K) did not un-
dergo any sensible crystallization phenomena. The bioactivity of
the obtained samples was tested in vitro in SBF with excellent results
Fig. 15. SEMmicrographs showing the internal structure of the SG BG_Ca/K shell scaffold (sample treated at T= 800 °C for 3 h) after soaking in SBF for 7 days (a, b, c) and EDS spectrum
(d) acquired on the area reported in (c).
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in the solution. Moreover, cytotoxicity tests performed with murine
ﬁbroblasts (BALB/3T3) show that the obtained SG glasses and their
extracts do not induce negative effects in cell viability. Finally, it
was possible to employ SG BG_Ca/K glass to manufacture highly po-
rous shell scaffolds, which remained almost amorphous. TheFig. 16.Morphological evaluation of BALB/3T3 cells after 24 h direct conobtained scaffolds were characterized by an open and fully intercon-
nected porosity and by a compact and permeable external surface,
which made them easy to handle (compression strength: 0.6–
0.7 MPa). On thebasis of these good outcomes, in the viewof a potential
application of the producedmaterials for bone tissue engineering, a full
biological characterization is in progress to integrate the cytotoxicitytact with the samples using optical microscopy 140× magniﬁcation.
Fig. 17. (a) NR uptake after 24 h in the different samples and (b) XTT test results.
585D. Bellucci et al. / Materials Science and Engineering C 43 (2014) 573–586results presented here. Moreover, a deeper insight into the mechanical
behavior of the obtained scaffolds could be of interest. These ﬁndings
will be the subject of speciﬁc future works.
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